{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:33:08Z","timestamp":1792200788689,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual & Reproductive Healthcare"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.srhc.2019.100459","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:29:27Z","timestamp":1565724567000},"page":"100459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Levels of option B+ ART drugs adherence and associated factors among pregnant women following ART services at public health facilities of East Shawa Zone, Oromia, Ethiopia"],"prefix":"10.1016","volume":"22","author":[{"given":"Mihretu","family":"Tarekegn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ararso","family":"Baru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assefa","family":"Seme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.srhc.2019.100459_b0005","unstructured":"UNAIDS. How AIDS Changed Everything? 2016."},{"key":"10.1016\/j.srhc.2019.100459_b0010","unstructured":"UNAIDS. Global Fact sheet HIV\/AIDS; 2014."},{"issue":"5","key":"10.1016\/j.srhc.2019.100459_b0015","first-page":"445","article-title":"Retention in care and medication adherence: current challenges to antiretroviral therapy success","volume":"75","author":"Holtzman","year":"2015","journal-title":"Dep Heal Hum Serv"},{"key":"10.1016\/j.srhc.2019.100459_b0020","unstructured":"UNAIDS. The gap report: Beginning of the End of the AIDS Epidemic. J Int AIDS Soc; 2015."},{"key":"10.1016\/j.srhc.2019.100459_b0025","unstructured":"WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. Geneva, Switzerland: WHO Press; 2010."},{"key":"10.1016\/j.srhc.2019.100459_b0030","unstructured":"WHO. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Programmatic update. Geneva, Switzerland; 2012."},{"key":"10.1016\/j.srhc.2019.100459_b0035","unstructured":"UNICIEF. Option B and B+: Key Considerations for Countries to Implement Equity Focused-Approach; 2012."},{"key":"10.1016\/j.srhc.2019.100459_b0040","unstructured":"FDRE\/MOH. National comprehensive PMTCT\/MNCH\/RH training package reference manual; 2013."},{"key":"10.1016\/j.srhc.2019.100459_b0045","unstructured":"FDRE\/MOH. Country Progress Report on the HIV. Addis Ababa, Ethiopia; 2014."},{"issue":"3","key":"10.1016\/j.srhc.2019.100459_b0050","first-page":"1","article-title":"Current scenario of HIV\/AIDS, treatment options, and major challenges with compliance to antiretroviral therapy the infection","volume":"8","author":"Bhatti","year":"2016","journal-title":"Cureus"},{"issue":"Suppl 2","key":"10.1016\/j.srhc.2019.100459_b0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/jit110","article-title":"Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes","volume":"207","author":"Paredes","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.srhc.2019.100459_b0060","article-title":"Medication adherence and health outcomes of people living with HIV who are food insecure and prescribed antiretrovirals that should be taken with food","volume":"79\u201391","author":"Kalichman","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.srhc.2019.100459_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021048","article-title":"Long-term costs and health impact of continued global fund support for antiretroviral therapy","volume":"6","author":"Stover","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.srhc.2019.100459_b0070","first-page":"188","article-title":"Lessons learned from early implementation of option B+: the Elizabeth Glaser Pediatric AIDS Foundation Experience in 11 African Countries","volume":"67","author":"Kieffer","year":"2015","journal-title":"J. AIDS"},{"issue":"2","key":"10.1016\/j.srhc.2019.100459_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0149527","article-title":"Why Did I Stop? Barriers and facilitators to uptake and adherence to ART in Option B+ HIV Care in Lilongwe Malawi","volume":"11","author":"Kim","year":"2016","journal-title":"PLoS One"},{"issue":"17994","key":"10.1016\/j.srhc.2019.100459_b0080","article-title":"Frequency and factors associated with adherence to and completion of combination antiretroviral therapy for prevention of mother to child transmission in western Kenya","volume":"16","author":"Ayuo","year":"2013","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.srhc.2019.100459_b0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijid.2014.12.026","article-title":"Level of adherence and predictors of adherence to the Option B+ PMTCT programme in Tigray, northern Ethiopia","volume":"33","author":"Ebuy","year":"2015","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.srhc.2019.100459_b0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1758-2652-14-50","article-title":"Current status of medication adherence and infant follow up in the prevention of mother to child HIV transmission programme in Addis Ababa: a cohort study","volume":"14","author":"Mirkuzie","year":"2011","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.srhc.2019.100459_b0095","unstructured":"Steel G, Joshi MP. Development of a multi-method tool to measure art adherence in resource-constrained settings: the South Africa experience. Management Sciences for Health, 4301 North Fairfax Drive, Suite 400. Arlington, VA 22203 USA: Rational Pharmaceutical Management Plus Program Center for Pharmaceutical Management; 2007."},{"issue":"258","key":"10.1016\/j.srhc.2019.100459_b0100","first-page":"1","article-title":"Longitudinal adherence to antiretroviral drugs for preventing mother-to-child transmission of HIV in Zambia","volume":"15","author":"Okawa","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"issue":"3","key":"10.1016\/j.srhc.2019.100459_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001015","article-title":"Triple-antiretroviral prophylaxis to prevent mother-to- child HIV transmission through breastfeeding \u2014 The Kisumu Breastfeeding Study, Kenya: a clinical trial","volume":"8","author":"Thomas","year":"2011","journal-title":"Plos Med"},{"key":"10.1016\/j.srhc.2019.100459_b0110","article-title":"Loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi: understanding outcomes and reasons","author":"Tweya","year":"2014","journal-title":"J Int AIDS Soc"},{"issue":"e2016043","key":"10.1016\/j.srhc.2019.100459_b0115","first-page":"1","article-title":"Levels of adherence and factors associated with adherence to option B+ prevention of mother-to-child transmission among pregnant and lactating mothers in selected government health facilities of South Wollo Zone, Amhara Region, northeast","volume":"38","author":"Tsegaye","year":"2016","journal-title":"Epidemiol Health"},{"issue":"20662","key":"10.1016\/j.srhc.2019.100459_b0120","first-page":"1","article-title":"Factors associated with loss to follow-up among women in Option B \u00e2\u20acTM PMTCT programme in northeast Ethiopia: a retrospective cohort study","volume":"19","author":"Mitiku","year":"2016","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"10.1016\/j.srhc.2019.100459_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021020","article-title":"Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania","volume":"6","author":"Kirsten","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.srhc.2019.100459_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6874-13-2","article-title":"Knowledge, perception about antiretroviral therapy (ART) and prevention of mother-to-child- transmission (PMTCT) and adherence to ART among HIV positive women in the Ashanti Region, Ghana: a cross-sectional study","volume":"13","author":"Boateng","year":"2013","journal-title":"BMC Women\u2019s Health"},{"key":"10.1016\/j.srhc.2019.100459_b0135","article-title":"Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women","volume":"6","author":"Ekama","year":"2013","journal-title":"J Pregnancy"},{"issue":"993","key":"10.1016\/j.srhc.2019.100459_b0140","first-page":"1","article-title":"Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine","volume":"14","author":"Bailey","year":"2014","journal-title":"BMC Public Health"},{"issue":"August","key":"10.1016\/j.srhc.2019.100459_b0145","first-page":"238","article-title":"Prevalence and determinants of non-adherence to antiretroviral therapy among HIV- positive pregnant women in Nnewi, Nigeria","volume":"2","author":"Igwegbe","year":"2010","journal-title":"Int J Med Med Sci."},{"issue":"7","key":"10.1016\/j.srhc.2019.100459_b0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/13691058.2011.583682","article-title":"Reasoning and deciding PMTCT-adherence during pregnancy among women living with HIV in Kenya","volume":"13","author":"Awiti","year":"2011","journal-title":"Cult Health Sex"},{"key":"10.1016\/j.srhc.2019.100459_b0155","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4236\/wja.2013.31003","article-title":"Factors that influence anti-retroviral therapy adherence among women in Lilongwe Urban Health","volume":"3","author":"Mbirimtengerenji","year":"2013","journal-title":"World J AIDS"},{"key":"10.1016\/j.srhc.2019.100459_b0160","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/09540120701660379","article-title":"Conceptualizing antiretroviral adherence in Beijing, China","volume":"20","author":"Starks","year":"2008","journal-title":"AIDS Care"},{"key":"10.1016\/j.srhc.2019.100459_b0165","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/09540120500161835","article-title":"A qualitative study of persons who are 100% adherent to antiretroviral therapy","volume":"18","author":"Lewis","year":"2006","journal-title":"AIDS Care"},{"issue":"450:9","key":"10.1016\/j.srhc.2019.100459_b0170","first-page":"1","article-title":"Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania","volume":"13","author":"Ngarina","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.srhc.2019.100459_b0175","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/09540120903499212","article-title":"Stigma as experienced by women accessing prevention of parent-to-child transmission of HIV services in Karnataka, India","volume":"22","author":"Rahangdale","year":"2010","journal-title":"AIDS Care"}],"container-title":["Sexual & Reproductive Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877575619300989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877575619300989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T04:56:20Z","timestamp":1761800180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877575619300989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":35,"alternative-id":["S1877575619300989"],"URL":"https:\/\/doi.org\/10.1016\/j.srhc.2019.100459","relation":{},"ISSN":["1877-5756"],"issn-type":[{"value":"1877-5756","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levels of option B+ ART drugs adherence and associated factors among pregnant women following ART services at public health facilities of East Shawa Zone, Oromia, Ethiopia","name":"articletitle","label":"Article Title"},{"value":"Sexual & Reproductive Healthcare","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.srhc.2019.100459","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100459"}}